Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Primary African Isolates

Novel therapeutic and preventive strategies are needed to contain the HIV-1 epidemic. Broadly neutralizing human antibodies (bNAbs) with exceptional activity against HIV-1 are currently being tested in HIV-1 prevention trials. The selection of anti-HIV-1 bNAbs for clinical development was primarily...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Virol
Main Authors: Lorenzi, Julio C. C., Mendoza, Pilar, Cohen, Yehuda Z., Nogueira, Lilian, Lavine, Christy, Sapiente, Joseph, Wiatr, Marie, Mugo, Nelly R., Mujugira, Andrew, Delany, Sinead, Lingappa, Jairam, Celum, Connie, Seaman, Michael S., Caskey, Marina, Nussenzweig, Michel C.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2021
Assuntos:
Pathogenesis and Immunity
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8092834/
https://ncbi.nlm.nih.gov/pubmed/33298542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01909-20
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados